Application of Thrombin Gel Matrix for the Prevention of Lymphocele in Patients With Endometrial Cancer.

• Status: Completed
• Trial end date: 2020-07-02
• Target enrollment: 0
• Participant gender: Female

Summary

To compare the incidence of lymphocele in Endometrial cancer patients with thrombin gel matrix used and not used during pelvic lymph node dissection.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Kocaeli University
• Treatments: Thrombin

Criteria

Inclusion Criteria:

• Endometrial cancer patients who need laparotomic bilateral PLND

• Patients suitable for surgery

Exclusion Criteria:

• Previous pelvic surgery

• Previous Chemotherapy or Radiotherapy

• Patients who undergo only lymph node sampling

• Patients who have not signed Informed Consent